Sitosterolemia: platelets on high-sterol diet

Slides:



Advertisements
Similar presentations
RNA interference in biology and disease by Carol A. Sledz, and Bryan R. G. Williams Blood Volume 106(3): August 1, 2005 ©2005 by American Society.
Advertisements

Human platelets synthesize and express functional tissue factor by Olga Panes, Valeria Matus, Claudia G. Sáez, Teresa Quiroga, Jaime Pereira, and Diego.
Rac GTPases play critical roles in early T-cell development by Celine Dumont, Agnieszka Corsoni-Tadrzak, Sandra Ruf, Jasper de Boer, Adam Williams, Martin.
Dosing lepirudin in patients with heparin-induced thrombocytopenia and normal or impaired renal function: a single-center experience with 68 patients by.
Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease by Marilyn J. Telen Blood Volume 127(7): February 18, 2016 ©2016 by.
Evidence for anti-inflammatory activity of statins and PPARα activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes.
Formation of human hepatocytes by human hematopoietic stem cells in sheep by Graça Almeida-Porada, Christopher D. Porada, Jason Chamberlain, Ali Torabi,
Multiple roles of the coagulation protease cascade during virus infection by Silvio Antoniak, and Nigel Mackman Blood Volume 123(17): April 24,
Adeno-Associated Viral Vector-Mediated Gene Transfer of Human Blood Coagulation Factor IX Into Mouse Liver by Hiroyuki Nakai, Roland W. Herzog, J. Nathan.
Determination of acute lung injury after repeated platelet transfusions by Laurence Corash, Jin Sying Lin, Claire D. Sherman, and Joseph Eiden Blood Volume.
Gene therapy: efficient targeting of hematopoietic stem cells
Modulation of hemostatic mechanisms in bacterial infectious diseases
Hydroxyurea makes inflammation “just right”?
VEGF therapy: risky business for established plaques?
Activation of αIIbβ3 is a sufficient but also an imperative prerequisite for activation of α2β1 on platelets by Gerlinde R. Van de Walle, Anne Schoolmeester,
Platelets come back in from the cold
TCR-MHC-peptide(s): in vivo veritas
“Vitamin hypothesis”: explanation for allergy increase?
Triple play of H pylori in ITP
by Henrik Frederiksen, and Kai Schmidt
Bulging glands? Blame it on B cells
Platelet Antibody Testing in Idiopathic Thrombocytopenic Purpura
Thanks for the complement (inhibitor)‏
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.
How I treat thalassemia
by Zhenping Zhu Blood Volume 108(6): September 15, 2006
PMNs deliver first aid to clot
Transplants for the elderly in myeloma
Elevated Plasma Von Willebrand Factor and Decreased ADAMTS13 Antigen Levels in Patients with Immune Thrombocytopenia (ITP)‏ by Charlotte Louise Godfrey,
FNAIT: the fetus pleads guilty!
Gnawing at Metchnikoff’s paradigm
Important port for SHIP-1 at Dok-3
The role of complete response in multiple myeloma
by Petri Salven, Lasse Teerenhovi, and Heikki Joensuu
An event of shear importance
Linkage between the mechanisms of thrombocytopenia and thrombopoiesis
Fluorescent neutrophils throw the spotlight on inflammation
Alterations in platelet secretion differentially affect thrombosis and hemostasis by Smita Joshi, Meenakshi Banerjee, Jinchao Zhang, Akhil Kesaraju, Irina.
In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation by Bethan Psaila, James B. Bussel, Matthew.
Deep mining of the RBC proteome
by Wolfram Springer, Alexander von Ruecker, and Roswitha Dickerhoff
Acute promyelocytic leukemia, microgranular variant
Thrombin generation: biochemical possibilities and clinical reality
by Julia E. Geddings, and Nigel Mackman
An actuarial GPS for hemophilic longevity
Taking a leaf from the book of oral tolerance
by Rocio Gonzalez-Conejero, Maria L
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
by Robert McMillan, Jennifer Lopez-Dee, and Joseph C. Loftus
Stage C or not stage C…? by Claire Dearden Blood
ROCK and Rho(ll) in bone marrow
by Anne-lie Ståhl, Lisa Sartz, and Diana Karpman
Blocking VWF platelet binding to treat TTP
Latest lymphoma classification is skin deep
Lymphoma spread? Target CD47-SIRPα!
by J. Evan Sadler Blood Volume 112(1):11-18 July 1, 2008
A new red cell shape helps the clot
Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.
Platelets and hemostasis: a new perspective on an old subject
Platelet spreading on immobilized fibrinogen.
Platelet ATP secretion in response to agonist stimulation.
Aggregation tracings of platelets lacking PLCβ2/β3.
How I treat disseminated intravascular coagulation
A binding relationship with thrombin
Myeloproliferative neoplasms and thrombosis
by Chatree Chai-Adisaksopha, Davide Matino, and Alfonso Iorio
Initial treatment of CLL: integrating biology and functional status
Consequences of complement activation.
Cancer-associated pathways and biomarkers of venous thrombosis
A schematic diagram showing the mechanism by which L5 triggers platelet activation and aggregation. A schematic diagram showing the mechanism by which.
Presentation transcript:

Sitosterolemia: platelets on high-sterol diet by Hervé Falet Blood Volume 122(15):2534-2535 October 10, 2013 ©2013 by American Society of Hematology

Impaired ABCG5/ABCG8 heterodimer function in Abcg5−/− or Abcg8−/− hepatocytes and enterocytes leads to increased plasma sterol levels. Impaired ABCG5/ABCG8 heterodimer function in Abcg5−/− or Abcg8−/− hepatocytes and enterocytes leads to increased plasma sterol levels. Sterols accumulate in the platelet membrane, resulting in calpain activation, reduced αIIbβ3 surface expression, loss of the GPIbα-FlnA linkage, microparticle formation, and poor hemostatic functions. Hervé Falet Blood 2013;122:2534-2535 ©2013 by American Society of Hematology